NDC product
Ketotifen Fumarate
NDC 0536-1252 · Rugby Laboratories
Key facts
| Product NDC | 0536-1252 |
|---|---|
| Proprietary name | Ketotifen Fumarate |
| Nonproprietary name | Ketotifen Fumarate |
| Substances | KETOTIFEN FUMARATE |
| Dosage form | SOLUTION/ DROPS |
| Route | OPHTHALMIC |
| Labeler | Rugby Laboratories |
| Product type | HUMAN OTC DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Application number | NDA021996 |
| Pharmacologic classes | Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Inhibitor [EPC] |
| Marketing start | Sep 18, 2020 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: